EC

Euclidean Capital Portfolio holdings

AUM $369M
1-Year Est. Return 26.98%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$369M
AUM Growth
+$131M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
12
New
Increased
Reduced
Closed

Top Buys

1 +$97.8M
2 +$30M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$64.5B
$220M 59.53%
2,990,084
+411,900
VTV icon
2
Vanguard Value ETF
VTV
$170B
$99.3M 26.88%
+520,000
INDA icon
3
iShares MSCI India ETF
INDA
$6.61B
$20M 5.41%
369,600
FHTX icon
4
Foghorn Therapeutics
FHTX
$311M
$8.5M 2.3%
1,573,761
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.2B
$8.09M 2.19%
989,410
PMVP icon
6
PMV Pharmaceuticals
PMVP
$73.6M
$3.28M 0.89%
2,627,643
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$720B
$2.8M 0.76%
4,104
RAPT
8
DELISTED
RAPT Therapeutics
RAPT
$2.79M 0.75%
82,234
ALEC icon
9
Alector
ALEC
$284M
$2.04M 0.55%
1,307,858
SRZN icon
10
Surrozen
SRZN
$363M
$1.98M 0.54%
87,696
TNYA icon
11
Tenaya Therapeutics
TNYA
$170M
$723K 0.2%
1,015,705
SRZNW icon
12
Surrozen Inc Warrant
SRZNW
$61.3K
$3.42K ﹤0.01%
170,833